Document is current
Any future updates will be listed below
-
Authors
Joosten, M. D. W.
Clabbers, J. M. K.
Jonca, N.
Mazereeuw-Hautier, J.
Gostyński, A. H. https://orcid.org/0000-0002-1091-2914
- License Information
-
More Information
Article History
Received: 17 March 2022
Accepted: 30 June 2022
First Online: 15 July 2022
Declarations
:
: Not applicable.
: Not applicable.
: AG: speakers fee by Abbvie for a presentation about genodermatosis on a Dutch dermatology congress, including data about treatment of ichthyosis by IL-17 inhibitors; stocks AstraZeneca, Abott Laboratories, Abbvie, GSK, Incyte Corp, Krystal Biotech Inc, Sanofi, Johnson and Johnson, Novartis, Pfizer, UCB; Novartis is providing secukinumab free of charge for four patients with ichthyosis treated in my centre. The other authors declare that they have no competing interests.
